Novogene Co Ltd
SSE:688315
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novogene Co Ltd
SSE:688315
|
CN |
|
Rite Aid Corp
OTC:RADCQ
|
US |
|
Semen Indonesia (Persero) Tbk PT
IDX:SMGR
|
ID |
|
G
|
Golden Heaven Group Holdings Ltd
NASDAQ:GDHG
|
CN |
|
Kore Potash PLC
LSE:KP2
|
UK |
|
A
|
Aciselsan Acipayam Seluloz Sanayi ve Ticaret AS
IST:ACSEL.E
|
TR |
|
Kerry Logistics Network Ltd
HKEX:636
|
HK |
|
K
|
Korea Line Corp
KRX:005880
|
KR |
|
M
|
Murray Cod Australia Ltd
ASX:MCA
|
AU |
|
2Invest AG
XETRA:2INV
|
DE |
|
S
|
Stockland Corporation Ltd
OTC:STKAF
|
AU |
|
Emmaus Life Sciences Inc
OTC:EMMA
|
US |
Wall Street
Price Targets
Price Targets Summary
Novogene Co Ltd
According to Wall Street analysts, the average 1-year price target for
Novogene Co Ltd
is 16.1 CNY
with a low forecast of 15.51 CNY and a high forecast of 17.33 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Novogene Co Ltd's stock price target?
Price Target
16.1
CNY
According to Wall Street analysts, the average 1-year price target for
Novogene Co Ltd
is 16.1 CNY
with a low forecast of 15.51 CNY and a high forecast of 17.33 CNY.
What is Novogene Co Ltd's Revenue forecast?
Projected CAGR
11%
For the last 5 years the
compound annual growth rate for
Novogene Co Ltd's revenue is
7%.
The projected
CAGR
for the next 3 years is
11%.
What is Novogene Co Ltd's Operating Income forecast?
Projected CAGR
13%
For the last 5 years the
compound annual growth rate for
Novogene Co Ltd's operating income is
11%.
The projected
CAGR
for the next 3 years is
13%.
What is Novogene Co Ltd's Net Income forecast?
Projected CAGR
13%
For the last 5 years the
compound annual growth rate for
Novogene Co Ltd's net income is
11%.
The projected
CAGR
for the next 3 years is
13%.
